相关实验视频

Updated: May 21, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

聚合物纳米系统:一种突破性的治疗炎症和炎症相关疾病的方法

Maja D Markovic¹, Vesna V Panic¹, Rada V Pjanovic²

¹Innovation Center of Faculty of Technology and Metallurgy, University of Belgrade, Belgrade, Serbia.

|March 19, 2025

概括

聚合物纳米系统 (PS) 提供了一种安全有效的方法来提供抗炎药物 (AID),克服诸如毒性和治疗炎症相关疾病 (IRD) 的生物可用性差等局限性. 这项技术有望增加临床使用,以改善患者的治疗结果.

科学领域:

生物材料科学生物材料科学
纳米技术纳米技术
药理学药理学是指药理学的学科.

背景情况:

炎症过程会造成严重的损伤,并导致许多与炎症相关的疾病 (IRD),包括癌症和神经,血管和肺部疾病.
传统的抗炎药物 (AID) 面临诸如高剂量,毒性,低生物可用性,溶解性差,副作用等局限性,阻碍有效治疗.
聚合物纳米系统 (PS) 已成为解决IRD处理中这些挑战的有希望的技术.

研究的目的:

提供聚合物纳米系统 (PS) 的概述,用于治疗与炎症相关的疾病 (IRD).
讨论三类PS的特性,制备和应用:树枝状分子,聚合物微粒/纳米粒子和聚合物细分细胞.
突出PS克服与传统抗炎药物 (AID) 相关的局限性的潜力.

主要方法:

关于用于抗炎药物输送的聚合物纳米系统的当前文献的审查和综合.
将PS分类为树枝状体,聚合物微粒/纳米粒子和聚合物细分细胞.
分析PS的特性,制备方法及其在治疗各种炎症相关疾病中的具体应用.

主要成果:

聚合物纳米系统 (PS) 证明了多功能性,生物相容性,低毒性和可调节性质,用于有效的AID封装和有针对性的输送.
特定类型的PS,包括树枝状体,聚合物微粒,纳米颗粒和细分细胞,显示出克服传统AID的局限性的潜力.
PS能够精确地将抗炎药物输送到目标部位,从而提高IRD的治疗疗效.

结论:

聚合物纳米系统 (PS) 通过改善抗炎药物 (AID) 输送,在治疗与炎症相关的疾病 (IRD) 中取得了重大进展.
与传统的AID相比,PS的多功能性和有针对性的传递能力提供了更安全,更有效的治疗策略.
越来越多的注意力和PS配方的发展表明,在临床实践中,用于管理IRD的作用越来越大.

关键词:

树枝状的树枝体.这是一种炎症炎症炎症炎症.聚合物细分体的聚合物细分体聚合物米塞尔的结构聚合物纳米粒子的聚合物纳米粒子.有针对性的药物输送.

更多相关视频

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

相关概念视频

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Inflammation

Inflammation

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...